Clinical Trials Directory

Trials / Unknown

UnknownNCT04324086

Effect of Removal of Intracanal Medication on Post Operative Pain

Post Operative Pain After Removal of Calcium Hydroxide With Different Activation Techniques

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Minia University · Academic / Other
Sex
All
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

Recruited patients with necrotic pulp after application of Calcium hydroxide are assigned to group (XP Endo Finisher file) and group( Passive ultrasonic irrigation) and group (conventional syringe irrigation with side vented needle) to remove intracanal medication and record postoperative pain afterwards.

Detailed description

The investigator will recruit patients who are found eligible to the criteria, Calcium hydroxide will be inserted inside the canals. After 7 days, patients will be randomly assigned to either removal of intracanal medication using, the XP-Endo Finisher file, passive ultrasonic irrigation (PUI) and conventional syringe irrigation with side vented needle. After the visit, patients will be asked to record post operative pain by Visual Analog Scale)in a given sheet

Conditions

Interventions

TypeNameDescription
DEVICECalcium hydroxide with XP-endo Finisher fileXP-endo Finisher files (FKG Dentaire, La Chaux-de-Fonds, Switzerland). file will be used with an endodontic motor X-Smart (Dentsply Sirona, Ballaigues, Switzerland) in removal of calcium hydroxide
DEVICECalcium hydroxide with Irrisafe Ultrasonic tippassive ultrasonic irrigation (PUI) with an IrriSafe Ultrasonic tips (Acteon,France), which will be driven by an ultrasonic device (Newtron P5, Satelec, Acteongroup, Merignac, France) in reemoval of calcium hydroxide
DEVICECalcium hydroxide with side vented needleconventional syringe irrigation with side vented needle (prime Dent, India) in removal of calcium hydroxide

Timeline

Start date
2020-04-01
Primary completion
2020-06-01
Completion
2020-10-01
First posted
2020-03-27
Last updated
2020-03-27

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04324086. Inclusion in this directory is not an endorsement.